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The Role of the Molecular Genetic 
Approach in the Pathogenesis of 
Endometriosis
Alfredo Borges Garnica
Abstract
Advances in cytogenetic, molecular genetic, and molecular cytogenetic techniques 
have provided convincing evidence in favor of a genetic basis for endometriosis and 
corroborating the higher prevalence of the disease in first-degree relatives of affected 
women. The regulatory mechanisms involved in the morphological and biochemical 
differentiation of the uterine endometrium are obviously complex, but consistent 
somatic genetic alterations have been identified. A higher percentage of aberrant meta-
phases showing aneuploidy, dicentric chromosomes, endomitosis, and chromosomal 
spraying have been detected in several trials. These results were further amplified by 
multicolored fluorescent in situ hybridization (FISH) analysis demonstrating the pres-
ence of alterations, where at least chromosomes 1, 16, 17, and 22 show structural aber-
rations containing genes that could play a role in the development and/or progression of 
endometriosis. Overall, the non-random distribution along with the subchromosomal 
location of the genetic alterations strongly supports the idea that these anomalies are 
relevant and are associated with the endometriotic process.
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1. Introduction
Endometriosis is a systemic, multisymptomatic, and disabling condition for 
women. Even when endometriosis originates from pelvic implantation, it can 
spread to other bodily surfaces outside of it.
These endometriosis cells do not shed and migrate like endometrial cells. They 
remain in situ, causing hemorrhage and an inflammatory response during each 
hormonal cycle, conditioning the different symptoms and complications in each 
affected organ.
Although the pathophysiological mechanism has been well studied, the cause 
of endometriosis remains uncertain. This fact has motivated the development of 
multiple and diverse theories that have tried to explain this pathology. The biggest 
problem is that they have been exclusionary theories, so they have not been able to 
define a cause that fits different scenarios.
It is under this concept and with the advent of new techniques of genetic and 
molecular study that new theories have been developed based on genetic changes 
and molecular alterations, which, being inclusive, provide a better vision of the 
origin of endometriosis and of the way it manages to develop much more effective 
therapeutic strategies.
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In this chapter, we will discuss some aspects of the molecular genetic approach, 
with relevant findings on the definition and pathogenesis of endometriosis
2. Understanding endometriosis
2.1 Theories of endometriosis
Endometriosis is an estrogen-dependent chronic inflammatory disease that 
primarily affects women of reproductive age and is defined as the presence of 
endometrial glands and stroma outside the uterine cavity [1].
The first reference of endometriosis appeared in 1690, when Daniel Shroen 
described the presence of “ulcers” disseminated in the pelvic cavity and that 
appeared only in women of reproductive age. From that date, different theories 
have been developed in an attempt to explain its origin; however, even today, 
endometriosis remains an enigmatic disease.
The pathogenesis of endometriosis can be included in six theories, which in turn 
can be subdivided into two groups depending on whether the implants come from 
the uterine or extrauterine endometrium [2].
2.1.1 Origin of uterine endometriosis
2.1.1.1 Theory of retrograde menstruation
It is the most widely accepted theory about the etiopathogenesis of endo-
metriosis. It was proposed in 1920 by Sampson. Menstruation ascends from the 
ostium, passes through the tubes and empties into the peritoneal cavity, with the 
subsequent implantation and growth of the endometrial fragments deposited 
in the peritoneal cavity. They represent an autotransplant, in which normal 
endometrial tissue is transplanted to an ectopic location in the body. This theory 
explains the higher frequency of endometriosis and the anatomical distribution 
of the lesions. However, it is not able to demonstrate the presence of endome-
triosis outside the peritoneal cavity, the appearance in early puberty, newborns, 
women affected by the Mayer-Rokitansky-Küster-Hauser syndrome or in the 
male [2, 3].
2.1.1.2 Theory of hematogenous or lymphatic dissemination of endometrial tissue 
(Halban theory)
It is based on the demonstration of ectopic endometrial tissue in locations dis-
tant from the uterus such as brain, lung, inguinal region, etc. However, on its own it 
is not capable of resolving its adhesion and progression capacity [2].
2.1.2 Origin of extrauterine endometrial endometriosis
2.1.2.1 The theory of coelomic metaplasia (Meyer’s theory)
The peritoneum and endometrium appear to have a common embryological pre-
cursor that is the coelomic epithelium. Dioxins are proposed as a possible external 
chemical agent that acts as an endocrine disruptor. This theory could explain why 
although most women have some degree of retrograde menstruation only a small 
percentage have endometriosis, as well as the presence of the disease in the absence 
of menstruation [3–5].
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2.1.2.2 Theory of endometrial stem cells
Stem cells in the circulation from bone marrow or from the basal layer of the 
endometrium could differentiate into endometrial tissue at different locations even 
from a distance. This theory would explain why women without endometriosis can 
have endometriosis, men with prostate cancer or after treatments can have high 
doses of estrogen [3, 4].
2.1.2.3 Theory of the Müllerian remains
Residual cells during embryonic development maintain the ability to develop 
endometriotic lesions influenced by estrogen stimulation [7].
2.1.3 Genetic predisposition
Endometriosis has a hereditary component. Susceptibility loci of the disease have 
been established in the 10q26 and 7p15 chromosomal regions. The endometrial cells 
need to adhere to each other and to the peritoneum, and integrins and cadherins 
participate in this process. Likewise, there is an upregulation of the antiapoptosis 
gene BCL-2 [5–7].
2.1.4 Hormone dependence
Endometriosis is an epigenetic disease in which the steroidogenesis factor 1, the 
estrogen, and progesterone receptors are hypomethylated in the ectopic endome-
trium causing a greater estrogenic effect locally. The endometriotic implants express 
aromatase and dehydrogenase of 17B-hydroxysteroid type 1, which are the enzymes 
responsible for converting androstenedione to estrone and estrone to estradiol. At 
the same time, there is a deficit of 17B-hydroxysteroid type 2, an enzyme respon-
sible for deactivating estrogen (passes estradiol to estrone), and estrogen receptors 
α and β are expressed differently, with a marked increase in β receptors, favoring all 
this a greater estrogenic environment [8–10].
2.1.5 Resistance to progesterone
Normal endometrial tissue does not express aromatase and produces abun-
dant dehydrogenase and 17B-hydroxysteroid type 2 in response to progesterone, 
ensuring the attenuation of estrogenic effects at the endometrial level during the 
luteal phase. In endometriosis, there is a relative resistance to progesterone that 
prevents the attenuation of the estrogenic stimulus. Prostaglandin E2 is the most 
potent inducer of aromatase activity in endometrial stromal cells and acts through 
the PGE2 receptor. The estradiol produced by the increased activity of aromatase 
increases the production of PGE2 for the stimulation of cyclooxygenase 2 in the 
endometrial cells of the uterus, causing a positive feedback that accentuates the 
estrogenic effects on the production of endometriosis [9].
2.1.6 Immunological factors
Different studies have shown the possibility that alterations in the immune system 
are responsible for the persistence of the ectopic endometrium, preventing immune 
mechanisms from eliminating endometrial cells within the peritoneal cavity [2].
These studies have shown a greater number of macrophages with altered func-
tion and alterations in the function of the natural killer cells, with a lower cytotoxic 
Molecular Bases of Endometriosis - The Integration Between Research and Clinical Practice
4
activity, in turn an alteration in the humoral immunity to observe an increase in 
the concentration of IgG endometrial antibodies as well as IgG and IgA antibodies 
against endometrial and ovarian tissue.
2.2 Pathogenesis of endometriosis
Regardless of the mechanism that promotes endometriosis, it is a fact the pres-
ence of endometrial cells with the potential to be implanted in the receptors tissues, 
especially in the mesothelium of the pelvic cavity.
In the pathological process of endometriosis in the pelvic organs such as the 
ovary, the clinical consequence is the formation of chocolate cysts, which can be 
explained in different ways: (i) during each hormonal cycle, bleeding occurs in the 
endometriosis accumulation, with an inversion and invagination of the epithelium. 
At the same time, a cellular inflammatory process begins with adhesions to the 
surrounding peritoneum. (ii) Chocolate or endometriosis cysts affect the follicular 
cyst of the ovarian epithelium. (iii) A process of celomic/endometriosis metaplasia 
of the ovarian epithelium.
At the peritoneal level, especially in the rectovaginal septum, a natural evolution 
of the peritoneal endometriosis of the Douglas pouch may be caused by secondary 
infiltration of endometriosis emboli or metaplasia of embryonic/müllerian remains 
located in the rectovaginal septum [10].
A permissive peritoneal environment for the initiation and progression of endo-
metriotic lesions may also be associated with the altered function of immune cells, 
together with local pelvic inflammatory processes that aid in the evasion of clear-
ance by the immune system. In addition to the amount of menstrual endometrium 
reflux present in the peritoneal cavity, the altered secretion of immune factors, the 
formation of autoantibodies, impaired immune recognition, and the elimination of 
ectopic endometrial cells facilitate the initiation and progression of endometriosis. 
Laschke and Menger suggest that the “gut microbiome” or “microenvironment” 
could be crucial in the pathogenesis of endometriosis through the aberrant priming 
of immune responses [11].
2.3 Local microenvironment, exosomes
The endometrial lesions are composed of the same structural units as the lining 
of the uterus, the endometrium. This glandular epithelium is positive for cyto-
keratin and is apparently composed of two cell types, namely, positive E-cadherin 
and very few negative E-cadherin cells. The endometriotic stromal cells express 
mesenchymal markers such as vimentin and THY-1 and can be distinguished from 
the surrounding fibroblasts by, for example, expression of the CD10 metallo-endo-
peptidase membrane (common acute lymphocytic leukemia antigen).
The adhesive, proliferative, and invasive properties of the endometriosis 
conjunctive tissue, as well as the cellular functions of this epithelium can be related 
to the components of its extracellular matrix [13, 14].
Thus, in the pathogenesis and progression of endometriosis, the local micro-
environment is vital to understand how endometriosis cells adapt to the control 
mechanisms of their host, escaping from immunological detections. The cell-stro-
mal intercommunication through paracrine, hormonal, and angiogenic messengers 
is vital for the perpetuity of endometriosis tissue [15–17].
In a model by Hull et al., comparing the microarray data obtained from a 
xenotransplant model and eutopic versus ectopic endometrial paired samples, they 
identified alterations in four pathways: cell injury (ubiquitin/proteasome), inflam-
mation (NFκB), tissue remodeling (TGF-β), and cell proliferation (KRAS). There is 
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thus an extensive metabolic reprogramming and the acquisition of changes similar 
to cancer that are reflected in an increase in the capacity of penetration and cellular 
penetration, a reduced apoptotic potential and an altered immune function [16].
The local microenvironment could also influence by altering gene expression 
through, for example, epigenetic changes (DNA methylation), histone modifica-
tions, and miRNA. The molecular networks associated with endometriosis are 
regulated by miRNA at the posttranscriptional level. In fact, 22 miRNAs aberrantly 
expressed in endometriotic lesions have been identified. In addition to differentially 
expressed miRNAs, the altered DNA methylation pattern occurs during the onset 
and/or progression of endometriosis. Since endometriosis is an estrogen-dependent 
but progesterone-resistant condition, it is not surprising that its respective pro-
moter regions are affected accordingly [17].
In addition to the epigenetic modifications, endometriotic cells also present 
chromosomal abnormalities and instability that could alter gene expression by loss 
or mutations of DNA sequences expressed as alterations in the signaling pathways 
in endometriotic cells (regulatory proteins) [8, 12, 13].
Endometriosis cells release extracellular vesicles, such as exosomes and microves-
icles, composed of various types of plasma membranes and origin of endosomal 
membrane, which are an alternative source for intercellular communication as they 
contain, for example, miRNAs with target genes in signaling pathways connected to 
the embryo-endometrial interface or enzymes and are capable of modulating cellu-
lar responses, for example, survival, differentiation, or modulation of immunogenic 
responses, important for endometriosis during implantation [18–23].
Exosomes containing ectonucleotidase could contribute to the progression 
of endometriosis and the local suppression of immune responses by regulating 
extracellular ATP and increasing extracellular adenosine levels [17].
They can also exert enhanced angiogenic effects. It is likely that the endometrial 
exosomes can be directed retrogradely in the pelvic cavity or can be detached by 
the menstrual cells and influence the fate of the ectopic cells. Thus, in the control 
of the local microenvironment, exosomes could be an important factor in allowing 
a temporary endometriotic lesion to establish a sufficient blood supply to grow and 
survive in the ectopic site. The endometrial exosomes of women with endometriosis 
act in an autocrine, paracrine, and endocrine fashion but in turn may play a role in 
the manifestation of endometriosis as a disease.
Diaphonia within the local microenvironments through the exosomes can rep-
resent the union intersection where the different theories about the pathogenesis of 
this entity converge. They could, through their ability to send information between 
tissue strains, to induce changes such as metaplasias, tissue remodeling, and even 
represent a mechanism of regulation/alteration in signal transduction [18].
2.4 Phenotype and cytogenetics of endometriosis
Ectopic endometrial cells have been little investigated, mainly due to the rare 
availability of endometriotic tissue required for cell culture and the limited num-
ber of cells, particularly those of epithelial phenotype. The proposed in vitro cell 
models have their limitations since the endometriotic lesions are histologically 
complex and contain both glandular and stromal elements. Therefore, cell lines 
immortalized with a cell type, which normally exhibit characteristics of undifferen-
tiated cells, do not accurately represent the situation in vivo. Thus, to evaluate the 
endometriosis phenotype, the cultures are prepared in general from biopsies of the 
various lesions [22, 23].
Among epithelial markers, cytokeratin expression remains one of the most 
specific characteristics of endometriosis cells. More than 40% of the cells were 
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immunoreactive with the anti-progesterone receptor (PR) antibody which shows a 
brown nuclear stain produced by the diaminobenzidine colorimetric reaction. Less 
than 15% are immunoreactive with the anti-androgen receptor antibody. Cytokeratins 
such as vimentin were expressed in endometriotic stromal cells. Therefore, most 
of the phenotypic characteristics of the normal endometrium are conserved in the 
endometriosis cells.
The existence of genomic aberrations in the tissues of endometriosis is probably 
related to genes involved in the development of the disease. Most genetic changes 
occur as germ line defects that can result in a hereditary predisposition to the devel-
opment of endometriosis with a genetic basis for endometriosis. The prevalence of 
the disease is higher in first-degree relatives of affected women than in the general 
population [21–23].
2.4.1 Chromosomal abnormalities observed in endometriotic cells, loss of 
heterozygosity
For decades, it has been a challenge to obtain consistent results on genetic 
abnormalities in endometriosis cells. The information produced by conventional 
cytogenetic and karyotypic studies is limited. The culture of pure endometriotic 
cells is hampered by the mixture of epithelial and stromal cells in addition to the 
inflammatory infiltrate containing fibroblasts and histiocytic cells; in addition, 
there may be excessive growth of normal cells [24].
Despite the difficulties, cytogenetic analysis plays an important role in the 
understanding of endometriosis, being the only technique that has the capacity to 
identify new chromosomal translocations, monosomies, and trisomies in chromo-
somes 11, 16, and 17.
Somatic genetic changes have been detected, distributed along several chromo-
somes, including chromosome 9p, 11q, and 22q. There have been allelic imbalances 
in 82% of endometriotic lesions diagnosed simultaneously with ovarian carcinoma.
These genetic studies have the limitation of having an adequate amount of 
endometriosis tissue from the patient and a simile of normal tissue to be used as 
control tissue, and in turn they have been limited to evaluating specific areas of the 
genome (detect loss of part of a chromosomal arm). But even so, they have been 
sufficiently useful to define the importance, in the development of endometriosis, 
of the inactivation of one or more suppressor genes [24–28].
2.4.2 Genetic aberrations by FISH: fluorescent in situ and hybridization 
comparative genomic hybridization
FISH is a technology that uses DNA probes labeled with a fluorophore to detect or 
confirm gene or chromosomal abnormalities that are generally beyond the resolution 
capability of routine cytogenetics. First, the DNA sample (metaphase chromosomes 
or interphase nuclei) is denatured, a process that separates the complementary 
strands of the double-stranded structure in the DNA double helix. To the denatured 
sample is then added the probe of interest, which will be associated to the DNA of 
the sample at the target site, in the process called hybridization, where a double helix 
is re-formed. The probe is covalently linked (labeled) with a fluorophore, which 
emits an observable signal through a fluorescence microscope; thus the DNA sample 
can be classified according to the presence or absence of the signal, which reveals the 
presence or absence of the target sequence in the chromosomal DNA.
Comparing the genetic analysis with the FISH analysis, we can see that the FISH, 
by not requiring endometriosis cell culture and avoiding the inconveniences of cel-
lular heterogeneity, has been more effective in revealing clonal aberrations such as 
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monosomy for chromosomes 16 and 17 and an increase in the number of cells with 
trisomy 11 [29–33].
The comparative genomic hybridization by arrays (CGH-a) allows to realize 
a molecular karyotype and detect alterations inferior to 10 Mb throughout the 
genome. The genomic DNA of the sample and a control sample are differentially 
labeled with fluorescent dyes and hybridized with the oligonucleotides. The results 
are analyzed using quantitative methods with analysis software to determine the 
number of copies. It will not detect low-level mosaicism, balanced translocations, 
inversions, or point mutations that may be responsible for the clinical phenotype.
This microarray analysis uses approximately 180,000 oligonucleotides that cover 
the entire genome at an average resolution of 30 KB, 1714 genes with all the exons 
covered, 700 microRNAs, and the entire mitochondrial genome [38, 39].
Through CGH-a, primary endometriotic lesions have been examined for gains 
and/or chromosomal losses. The losses that predominated over the gains showed 
a grouping in certain chromosomal regions that suggests a recurrent non-random 
pattern of chromosomal alterations.
The average number of alterations of the copy in our series of endometriotic 
tissues was 3.1 per injury, which is low compared to malignant tissues [21].
The most common regions of loss of genomic material have been located in 1p 
involving at least 1p32–36 (50%), 5p (33%), 6q (27%), 7p14-p22ter (22%), 16qter 
(22%), and 22q12.3-qter (50%) segments. The other less common changes in the 
number of copies included the loss involving the arms of chromosomes 9q (22%), 16q 
(22%), and 17q [21, 22, 24–29, 33].
Chromosome 1 deletions were particularly common in all types and stages of 
endometriosis tissues, including peritoneal implants, endometriomas, and umbili-
cal nodules. The gains were found less frequently and were located on chromosomes 
6q and 17q. Several novel regions located on chromosomes 1p, 6q, and 22q that 
could harbor single or multiple tumor suppressor genes involved in the pathogen-
esis of endometriosis have been identified [38, 39].
2.4.3 Chromosomal instability in endometrial lesions
Chromosomal instability in endometrial lesions is the alteration of the chromo-
somal constitution that takes place in diverse pathological conditions: fundamental 
characteristic of the neoplasic cells (the majority of the malignant and benign 
tumors), precancerous lesions (dysplasia, leukoplakia, and cystically altered tis-
sues), chronic inflammatory conditions, infectious diseases, and diseases induced 
by viruses (herpes, HPV, EBV, etc.).
Genomic instability is mainly caused by chromosomal alterations in non-
neoplastic precursor lesions and mutation of the P53 gene, and in errors in DNA 
replication detected by the instability of microsatellites (deficiency in the repair 
mechanism of DNA mismatch) [34, 35].
Endometriosis tissues present this instability, through the presence of chromo-
somal copies, numerical changes, chromosomal deletions, translocations, the presence 
of endomitosis, premature centromeric dislocations, and the presence of micronuclei.
The loss of essential genes or even of whole chromosomes explains the high 
invasive potential of endometriotic cells. The genomic alterations (rearrangements) 
initiated can be a primary event that facilitates the initiation and dissemination of 
endometriosis. It is the alteration of the chromosomal constitution that takes place 
in diverse pathological conditions: fundamental characteristic of the neoplasic cells 
(the majority of the malignant and benign tumors), precancerous lesions (dysplasia, 
leukoplakia, and cystically altered tissues), chronic inflammatory conditions, infec-
tious diseases, and diseases induced by viruses (herpes, HPV, EBV, etc.) [34–37].
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Figure 1. 
Exosomes containing ectonucleotidase could contribute to progression of endometriosis.
3. Conclusions
Endometriosis, even when in essence it is not a mortal disease, is a major health 
problem in general due to the disability it causes in young and fertile women, in full 
reproductive stage.
Genetic factors play a predominant role in approximately one-third of chronic 
disorders in adulthood; so, it is logical to think that endometriosis in turn presents 
a genetic etiology. Genetic diseases in general can be chromosomal, monogenic, or 
multifactorial. Currently, epigenetics attempts to explain genetic and environmen-
tal interactions and studies changes in gene expression mediated by mechanisms 
other than the sequence changes of their nucleotides. These epigenetic changes 
include DNA methylation, histone modification, and interfering RNA. Epigenetic 
alterations are associated with inflammation and persistence of the lesions. The 
results of research on the role of these changes in endometriosis are very valuable in 
the design of future therapeutic strategies.
Currently, epigenetic studies based on FISH technology and comparative genomic 
hybridization have shown important chromosomal alterations, especially in chromo-
somes 1, 16, 17, and 22, and it is believed with greater certainty that they are the loci 
involved in the persistence and progression of chromosomes. Endometriosis cells.
It is in these locations where there has been an instability of DNA information 
through mechanisms of deletions, translocations, which have led on the one hand 
to the loss of important genomic information (loss of heterogizity) in endometrial 
diploid cells, fundamental alterations in the self-regulation, and apoptosis of these 
aberrant endometrial cells, by mutations as occurs with the P53 gene. These altera-
tions not only occur in the endometriosis cell but are capable of being transmitted 
to other cells either in an autosomal manner when replicated, or through shared 
information through a microenvironment mediated by exosomes.
For the researchers, the process of analyzing cultured cells that reproduce the 
epigenetic changes of an endometriosis cell in vivo has been a feat, but the results of 
the investigation of the role of these changes in endometriosis have been very valu-
able and will be useful in the design of future therapeutic strategies (Figures 1–3).
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Appendices and nomenclature
Exosomes: are cell-derived vesicles that are present in many and perhaps all 
eukaryotic fluids, including blood, urine, and cultured medium of cell cultures.
Cadherin: is a group of cellular adhesive (membrane glycoprotein) that keeps 
cells tightly bound in time, favoring the organization of tissues and organs, facili-
tating the mobility of heterogeneous groups of cells.
Phenotype: A phenotype is the composite of an organism’s observable charac-
teristics or traits, such as its morphology, development, biochemical or physiologi-
cal properties, behavior, and products of behavior.
Figure 2. 
Clonal aberrations detected by FISH.
Figure 3. 
Summary of alterations in endometriosis.
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Cytokeratin: are keratin proteins found in the intracytoplasmic cytoskeleton 
of epithelial tissue. They are an important component of intermediate filaments, 
which help cells resist mechanical stress.
Heterozigosity: A heterozygote is an organism that has different alleles in a 
gene. This organism carries different forms of a gene, where those forms produce 
different phenotypic results. In each case, the same gene has slight variations.
Hybridization: is the process of interbreeding individuals from genetically 
distinct populations to produce a hybrid. A genetic hybrid would therefore carry 
two different alleles of the same gene.
Monosomy: the condition of having a diploid chromosome complement in 
which one (usually the X) chromosome lacks its homologous partner.
Trisomy: is a type of polysomy in which there are three instances of a particular 
chromosome, instead of the normal two. A trisomy is a type of aneuploidy (an 
abnormal number of chromosomes).
Deletion: is a mutation (a genetic aberration) in which a part of a chromosome 
or a sequence of DNA is lost during DNA replication. Any number of nucleotides 
can be deleted, from a single base to an entire piece of chromosome.
Translocation: is a chromosome abnormality caused by rearrangement of parts 
between nonhomologous chromosomes. A gene fusion may be created when the 
translocation joins two otherwise-separated genes.
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